EUCTR2013-003888-59-NL进行中(未招募)不适用
ADHD: Medication or Meditation?
niversity of Amsterdam0 个研究点目标入组 120 人开始时间: 2014年1月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- The child is between 9 and 18 years of age
- •- The child has a DSM classification of ADHD
- •- ADIS-C is administered
- •- (Estimated) IQ > 80
- •- At least one parent is willing to participate in the Mindful Parenting training
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 120
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- (Estimated) IQ < 80
- •- Suicidal ideation
- •- Suffering from psychosis or schizophrenia
- •- Co-morbid autism or Conduct Disorder
- •- Current or previous use of methylphenidate
- •- Participation in a currently active other psychological intervention
研究者
相似试验
尚未招募
不适用
My child has ADHD: Medication or Meditation?Attention Deficit Hyperactivity Disorder (ADHD)NL-OMON22179niversity of Amsterdam120
已完成
不适用
Mood treatment with antidepressants or runningangststoornissendepression and anxietymajor depressive disorder and anxiety disorder10027946NL-OMON39034GGZ inGeest (Amsterdam)270
已完成
不适用
The effecacy hypnotherapy on treatment of irritable bowel syndrome????? ???? ????? ????.Irritable bowel syndromeIRCT201210268253N2Shahrekord University of Medical Sciences34
招募中
不适用
Mindfulness training versus treatment as usual in adults with attention deficit hyperactivity disorder (ADHD)ADHDAttention deficit hyperactivity disorder10009841NL-OMON41102Radboudumc120
撤回
2 期
A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs AloneGeneralized Anxiety DisorderNCT04965272AbbVie
